Articles by Daniel Marsh
Neurocrine Acquires Soleno in $2.9B Deal for Rare Disease Drug Vykat XR
Neurocrine Biosciences will purchase Soleno Therapeutics in a $2.9 billion all-cash transaction, securing the commercial rights to Vykat XR. The deal offers $53 per share to Soleno stockholders.
Hologic CEO to Depart as $18.3B Private Equity Acquisition Nears Completion
Hologic announced CEO Steve MacMillan will step down once the company's $18.3 billion acquisition by Blackstone and TPG finalizes, expected around April 7. The deal will take the women's health technology firm private.
Amazon Imposes 3.5% Fuel Surcharge on Sellers Amid Rising Oil Prices
Amazon is introducing a 3.5% fuel and logistics surcharge on fulfillment fees for third-party sellers in the U.S. and Canada, effective April 17. The move comes as Brent crude oil prices hover around $110 per barrel, increasing delivery costs across the logistics sector.
Mortgage Rates Inch Lower, Affordability Squeeze Persists for Spring Buyers
U.S. mortgage rates edged down slightly, with the 30-year fixed average at 6.43%. However, purchase applications declined and the median monthly payment rose, highlighting ongoing affordability challenges.
Dow Gains on Ceasefire Hopes, But Oil and Fed Fears Linger
The Dow Jones Industrial Average advanced 0.18% to 46,587.48 by midday Monday, buoyed by optimism over potential Iran ceasefire negotiations. However, caution prevailed as oil prices remained elevated and expectations for Federal Reserve easing diminished.
Stocks Edge Higher on Geopolitical Hopes Amid Inflation, Rate Cut Concerns
Major U.S. stock indices rose Monday, buoyed by reports of renewed Iran ceasefire talks, though gains were tempered by persistent inflation worries and shifting expectations for Federal Reserve rate cuts.
JPMorgan Price Target Cut by Evercore Amid CEO's Geopolitical Warning
Evercore ISI reduced its JPMorgan Chase price target to $320 from $350, as shares traded near $296. CEO Jamie Dimon cautioned that war in Iran could trigger oil shocks and persistent inflation.
Major Investors Reduce Pfizer Holdings Amid Growth Transition
Three institutional investors trimmed their Pfizer positions by a combined 740,174 shares in the fourth quarter, filings show, as the pharmaceutical giant navigates its post-pandemic transition.
SCHD ETF Sees Strong Q1 Inflows After Dividend Hike and Portfolio Overhaul
The Schwab U.S. Dividend Equity ETF (SCHD) reported a 3.3% dividend increase and $4 billion in first-quarter inflows following a significant portfolio reshuffle that boosted healthcare and tech exposure while reducing energy holdings.
Deere's Tarter Partnership Targets Farm Implement Demand Amid Equipment Slowdown
Deere & Co. has partnered with Tarter USA to launch American-made Frontier flex-wing rotary cutters, targeting farmers who are delaying large equipment purchases but still buying implements. The company's shares gained 0.8% as initial dealer orders exceeded expectations.
Indian Equities Surge on Geopolitical Relief, Banks Lead Rally
Indian stock benchmarks jumped over 1% on Monday, with the Sensex climbing 787 points to 74,106.85, fueled by easing crude prices on potential Middle East de-escalation. Financial and consumer stocks led the advance.